NAD+ therapy is commonly used by individuals seeking support for energy production, mental clarity, healthy aging, recovery, and overall wellness
sometimes combined with mesotherapy or chemical peels for pigmentation goals
Virtual health care juggernaut Hims & Hers Health purchased a peptide manufacturing facility in February 2025 and is developing clinical protocols for peptides, according to its chief medical officer, Anant Vinjamoori, who is slated to testify at the FDA hearing
These include: Increased risk of seizures: Wellbutrins drug label includes a warning that the drug is associated with seizures in 0.4% of people who take 450 mg per dayand that can increase tenfold for people who take 600 mg per day
Additionally, nearly 54% of treatment programs integrate GLP-1 drugs as a primary solution for weight management
Wennerlund J, Gunnarsson U, Strigrd K, Sundbom M